Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-2 with or without ibuprofen for poor CD4 recovery in treated HIV infection
2007-006730-33Phase 4Active
- Sponsor
- Hospital Universitario Virgen del Rocío
- Start
- Mar 2008
- Modality
- Small Molecules, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of aldesleukin and ibuprofen in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Hospital Universitario Virgen del Rocío. Primary endpoints: Proportion of patients with significant CD4 increase and Median increase in CD4 count. Started Mar 2008; status: active.
02
Drugs
aldesleukinibuprofen
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2007-006730-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006730-33.